Orthobiologics and stem cells explained – Dr. Matthew Lucas with the Centeno-Schultz Clinic – The Stock Podcast, Ep.41

Update: 2019-10-25

Description

Orthobiologics are living substances like stem cells and platelet rich plasma (PRP) that some medical doctors use in the rehabilitation process. Dr. Matthew Lucas from the Centeno-Schultz Clinic, based out of Denver, CO, joins the podcast to explain the use of stem cells and PRP in medicine today.

The post Orthobiologics and stem cells explained – Dr. Matthew Lucas with the Centeno-Schultz Clinic – The Stock Podcast, Ep.41 appeared first on The Stock Podcast | CEO & CFO Interviews.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Final Episode with Nate Abercrombie – The Stock Podcast, Ep.49

2020-02-0401:37:52

The Current State of Midstream – Follow-up Interview with Chris Sighinolfi

2020-01-1301:08:48

The State of Midstream – Follow-Up Interview with Chris Sighinolfi – Jefferies Research Managing Director – The Stock Podcast, Ep. 48

2020-01-1301:08:48

EnLink Midstream (ENLC) CEO Barry Davis – The Stock Podcast, Ep.47

2020-01-0635:06

NRG Energy (NRG) CFO Kirk Andrews – Follow-Up Interview – The Stock Podcast, Ep.46

2020-01-0257:45

Kris Kelley – Legacy Ridge Capital Management – The Stock Podcast, Ep.45

2019-12-2501:39:47

Super League Gaming (SLGG) CEO Ann Hand – The Stock Podcast, Ep.44

2019-12-1601:01:44

Vistra Energy (VST) CEO Curt Morgan – The Stock Podcast, Ep.43

2019-12-1217:36

Concrete Pumping Holdings (BBCP) CEO Bruce Young – The Stock Podcast, Ep.42

2019-12-0958:38

Orthobiologics and stem cells explained – Dr. Matthew Lucas with the Centeno-Schultz Clinic – The Stock Podcast, Ep.41

2019-10-2501:21:48

Charles & Colvard (CTHR) CEO Suzanne Miglucci – The Stock Podcast, Ep.40

2019-10-0401:18:39

Saudi Oil, Iran, and The Abqaiq Attack – Professor Joshua Landis – The Stock Podcast, Ep.39

2019-09-2801:06:04

Oil Market Dynamics, Capacity Reserves, and Abqaiq – Cornerstone Analytics’ Mike Rothman – The Stock Podcast, Ep.38

2019-09-2816:00

Duke Austin – CEO of Quanta Services (PWR) – The Stock Podcast, Ep.37

2019-09-1801:10:33

Brad Slingerlend and Brinton Johns – Tech Investing with the Co-Founders of NZS Capital – The Stock Podcast, Ep.36

2019-09-0501:30:38

Mark Harding – CEO of Pure Cycle Corp (PCYO) – Follow-Up Interview – The Stock Podcast, Ep.35

2019-08-1901:02:26

Porter’s Five Forces for Podcasting – The Stock Podcast, Ep.34

2019-07-2429:41

Meg Gentle – CEO of Tellurian Inc (TELL) – The Stock Podcast, Ep.33

2019-07-0244:00

Gabriel Weinberg – CEO of DuckDuckGo – The Stock Podcast, Ep.32

2019-06-1101:36:01

Nolan Watson – CEO of Sandstorm Gold Royalties (SAND) – The Stock Podcast, Ep.31

2019-05-2401:13:45

00:00

Orthobiologics and stem cells explained – Dr. Matthew Lucas with the Centeno-Schultz Clinic – The Stock Podcast, Ep.41

#box-pro-ellipsis-173218577343618{-webkit-line-clamp:2;}Orthobiologics and stem cells explained – Dr. Matthew Lucas with the Centeno-Schultz Clinic – The Stock Podcast, Ep.41

Orthobiologics and stem cells explained – Dr. Matthew Lucas with the Centeno-Schultz Clinic – The Stock Podcast, Ep.41

Nate Abercrombie

Orthobiologics and stem cells explained – Dr. Matthew Lucas with the Centeno-Schultz Clinic – The Stock Podcast, Ep.41